Saturday, February 4th, 2012
UpLift Nutrition, Inc. (www.upliftnutrition.com) (OTCBB: UPNT), announced today it has signed a national distribution agreement with Mr. Checkout Distributors, Inc., one of the Nation’s largest independent retail distribution networks.
Under the terms of the contract agreement, UpLift Nutrition will be able to start placing its newest product, All Day Energy Spray? in up 17,000 or more, of their convenience type retail stores throughout the next year. The Mr. Checkout independent distributors will help with marketing by placing in store advertising materials in each of their locations and making sure pictures are taken showing our product placed in strategic places throughout the stores.
"We are very excited to get started with our product placement in these independent convenience stores. There are over 44,000 independent convenience type store owners in the US and this is a great start for UpLift Nutrition and our marketing efforts," said Gary Lewis, the Company’s President.
Mr. Checkout (www.mrcheckout.net) is an independently owned company with independently owned distributors serving independent store owners all over the Country. They currently have over 100 independent distributors that service those 17,000 plus stores and almost 15 wholesale-to-distributor product warehouse suppliers for more localized inventory storage and convenient shipping locations.
About UpLift Nutrition (www.upliftnutrition.com):
UpLift Nutrition’s mission is to utilize the latest and best science available to produce nutritional products. We will constantly strive to offer products that benefit all, while remaining mindful of protecting and preserving Mother Nature’s finite resources.
To view all of UpLift’s filings visit www.sec.gov, click on "Search for Company Filings" under the Filings & Forms heading, click on "Companies and Other Filers," and enter UpLift Nutrition.
This press release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update these statements to reflect actual results, changes in assumptions or other factors. Without limitation, these risks and uncertainties include the Company’s dependence on its ability to market this, or any other product the Company may attempt now or in the future. Readers should review and consider the various disclosures made by the Company in its reports to its shareholders and the Securities and Exchange Commission.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
